Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for REPLIGEN CORP COMMON STOCK (RGEN).
- Disclosed ownership: 6.1%.
- Date of event: 31 Aug 2025.
PRICE T ROWE ASSOCIATES INC /MD/ - 31 Aug 2025 SCHEDULE 13G/A Report for REPLIGEN CORP COMMON STOCK (RGEN)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Security
- REPLIGEN CORP COMMON STOCK
- Symbol
- RGEN
- Shares outstanding
- 56,222,082 shares
- Disclosed Ownership
- 3,429,547 shares
- Ownership
- 6.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Sep 2025, 13:35:52 UTC
- Date of event
- 31 Aug 2025
- Previous filing
- 14 Feb 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 6.1% ownership in REPLIGEN CORP COMMON STOCK (RGEN) on 31 Aug 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 08 Sep 2025, 13:35.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 6.1% | 3,429,547 | 3,170,704 | 0 | Ellen York | Vice President |